Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares OutstandingShares Repurchased
Ratios

Actinium Pharmaceuticals (ATNM) Shares Outstanding (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Shares Outstanding for 8 consecutive years, with $31.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed N/A to $31.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $31.2 million for FY2025, N/A changed from the prior year.
  • Shares Outstanding for Q4 2025 was $31.2 million at Actinium Pharmaceuticals, roughly flat from $31.2 million in the prior quarter.
  • The five-year high for Shares Outstanding was $31.2 million in Q3 2024, with the low at $19.2 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $26.6 million, with a median of $27.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding rose 17.92% in 2022, then changed 0.0% in 2025.
  • Over 5 years, Shares Outstanding stood at $22.1 million in 2021, then grew by 15.94% to $25.7 million in 2022, then rose by 7.63% to $27.6 million in 2023, then rose by 12.89% to $31.2 million in 2024, then changed by 0.0% to $31.2 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $31.2 million, $31.2 million, and $31.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.